Seelos Therapeutics Inc
NASDAQ:SEEL

Watchlist Manager
Seelos Therapeutics Inc Logo
Seelos Therapeutics Inc
NASDAQ:SEEL
Watchlist
Price: 0.39 USD -27.79% Market Closed
Market Cap: 100k USD

Intrinsic Value

The intrinsic value of one SEEL stock under the Base Case scenario is 75.02 USD. Compared to the current market price of 0.39 USD, Seelos Therapeutics Inc is Undervalued by 99%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SEEL Intrinsic Value
75.02 USD
Undervaluation 99%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

Seelos Therapeutics Inc
NASDAQ:SEEL
US
Pharmaceuticals
Market Cap
100k USD
IPO
Oct 27, 1993
US
Pharmaceuticals
Market Cap
100k USD
IPO
Oct 27, 1993
Price
$false
EPS
$false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Seelos Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Seelos Therapeutics Inc

Current Assets 2.3m
Cash & Short-Term Investments 294k
Receivables 188k
Other Current Assets 1.9m
Non-Current Assets 47k
PP&E 47k
Efficiency

Free Cash Flow Analysis
Seelos Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Seelos Therapeutics Inc

Revenue
2m USD
Operating Expenses
-31.8m USD
Operating Income
-29.8m USD
Other Expenses
33.9m USD
Net Income
4.1m USD
Fundamental Scores

SEEL Profitability Score
Profitability Due Diligence

Seelos Therapeutics Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

32/100
Profitability
Score

Seelos Therapeutics Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

SEEL Solvency Score
Solvency Due Diligence

Seelos Therapeutics Inc's solvency score is 21/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
21/100
Solvency
Score

Seelos Therapeutics Inc's solvency score is 21/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SEEL Price Targets Summary
Seelos Therapeutics Inc

There are no price targets for SEEL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Seelos Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for SEEL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

SEEL Insider Trading
Buy and sell transactions by insiders